Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients
Authors:
Open Access
- 31 July 2022
- journal article
- letter
- Published by Elsevier in Journal of Liver Transplantation
- Vol. 8, 100116
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant PatientsClinical Gastroenterology and Hepatology, 2022
- Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipientsJournal of Hepatology, 2021
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trialThe Lancet Infectious Diseases, 2021
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant RecipientsJAMA, 2021